Join
Live feed
·
INSIDERFilingvia Quantisnow
Aytu BioPharma Inc. logo

Director Donofrio John Jr. was granted 1,500 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AYTU· Aytu BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AYTU (Aytu BioPharma Inc.) and more on Quantisnow.